Want to join the conversation?
R&D focused biotechnology company $ENTA said that the FDA has approved AbbVie's supplemental New Drug Application (sNDA) for the use of VIEKIRA PAK without ribavirin (RBV) in patients with genotype 1b (GT1b) chronic hepatitis C virus infection and compensated cirrhosis, a liver-related disease.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.